Joel Michael Maryles, Director at Chemomab Therapeutics Ltd. (CMMB), bought 1,000 shares at $4.36 ($4K) on 2022-03-18, disclosed to the SEC on 2022-03-21.
Open-market purchase of $4k CMMB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.32 | 500 | $2K | 49.8% |
| 2 | $4.36 | 500 | $2K | 50.2% |
| Total | $4.34 avg | 1,000 | $4K | 100% |